Posted on Wed, Jan 02, 2013
Bound Brook, NJ, USA — December 20, 2012 - DZS Software Solutions, Inc., a provider of the ClinPlus software products and services supporting several aspects of clinical trials, today announced the acquisition of the Clinical Services and Business Development components of InQuiry Research, LLC to strengthen its DZS Clinical Services division that provide clinical data management, CDISC, biostatistics and medical writing expertise. The transaction includes resources, technology and processes allowing a seamless transfer and ensuring no interruption for established customers.
"This acquisition and the addition of Greg Ambra and his clinical team is a great complement to our company and further expand the DZS leadership position in the pharmaceutical, biotechnology, and medical device services space. This will allow us to provide more comprehensive capabilities in the US and globally,” said Doron Steger, President and Founder of DZS.
“Access to DZS clinical software expertise and resources will increase our capacity and allow us to offer a broader range of services. We look forward to the expanded the clinical service offerings we can provide our clients,” said InQuiry Research’s Managing Partner, Greg Ambra.
The DZS Clinical Services division is located at the DZS corporate headquarters in Bound Brook, New Jersey.
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 60 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite’s unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found in every system!
DZS Software Solutions conducts all design, development and validation work in their corporate offices the USA.
Posted on Fri, Oct 05, 2012
Bound Brook, NJ – October 5, 2012 – DZS Software Solutions (DZS), a provider of software products that support several aspects in the performance of clinical trials, today announced the official release of ClinPlus CTMS Version 2.1. This release builds on an already robust and flexible system with about 45 specific enhancements that are a direct result of user input.
Some of the most significant enhancements include:
- Microsoft SharePoint® Integration. This new feature will add the ability to define SharePoint Sites and use these sites to browse and download documents. This enables organizations to maintain their investment in SharePoint without needing to replicate copies of documents in CTMS. Alternately, documents may be linked to a local network file or uploaded to the CTMS database.
- Custom Fields. Invariably, users will want to capture information that is not included in the standard CTMS product but is specific to their organization or individual project requirements. This enhancement allows the users to create custom fields on nearly all global and project tables. These fields may be of any type (date, text, checkbox, dropdown, etc.) and can be used exactly like standard fields when defining custom reports (sorting, grouping, etc.).
- Vendor Costs. There are several new features that have been added to enable users to track costs and payments to vendors. This enables users to view the entire scope of the trial management costs from within the CTMS system.
- Site Pass-Thru Costs. This enhancement enables users to track Site Pass-Thru costs in addition to Subject-related costs for visits and events to get a full view of all Site costs for a clinical trial. The Pass-Thru Costs can be included in Budget Templates and Site Budgets, or can be added to a Site as a non-budgeted cost.
- Subject Event SAEs. Users can now assign a payment amount for each Serious Adverse Event reported by a Site. Like other Site costs in the CTMS system, the amount of the payment can be set in the Site Budget for each Site.
- Download to ZIP. Provides the ability to download all site documents for a selected site to an easy to email ZIP file.
DZS has earned a reputation as a leading provider Clinical Trials Management Systems thanks to the clean, intuitive design, flexibility and ease of implementation. “User acceptance is extremely important for a successful implementation of a system with a large user base such as CTMS”, said Steve Trigilio, CTMS Product Manager. “Our design philosophy stresses ease-of-use by providing a well organized, pleasant and consistent interface that users adapt to quickly with minimal training.” This philosophy coupled with a feature rich toolset, strong integration capabilities with EDC and IVRS systems, and simple configuration at the system and project level ensures a successful implementation and quick roll-out.
ClinPlus CTMS clients will receive this upgrade at no additional cost immediately including expert support to guide them through the upgrade process. DZS will always continue to support earlier versions of their software for those clients who choose not to upgrade right away.
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 60 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite’s unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found in every system!
DZS Software Solutions conducts all design, development and validation work in their corporate offices the USA.
Posted on Thu, Jul 12, 2012
Clinical Software Solutions Organization Announces the Achievement of Certification by the Uppsala Monitoring Centre
New York, NY/Bound Brook, NJ – June 15, 2012 – DZS Software Solutions (DZS), a provider of software products that support several aspects in the performance of clinical trials, today announced achievement of certification by the Uppsala Monitoring Centre (UMC) for their ClinPlus Coding product. The UMC Certification Program ensures that software vendors are providing tools that will give users full value and benefit of their WHO Drug Dictionary subscription. The WHO Drug Dictionaries are the world’s most comprehensive source of medicinal product information. They are used by pharmaceutical companies, clinical research organizations and drug regulatory authorities to identify drug names, active ingredients and therapeutic use, in the course of clinical trials and drug safety surveillance.
The current version of ClinPlus Coding was engineered for optimal performance with the WHO Drug Enhanced Dictionary with certification as a goal. The ClinPlus Coding software has past all test cases in the rigorous certification process demonstrating the ability to take full advantage of the ever evolving WHO Drug Dictionaries. The UMC certification also provides software developers with free training and a software development kit, including documentation and examples
“We were very impressed with the ClinPlus Coding system’s performance and features as the system was being put through the rigorous certification process. This system clearly demonstrated an excellent ability to work with the WHO Drug dictionaries in an efficient and intuitive manner.” - Ola Strandberg, Vendor Liaison Officer
“Though this certification is certainly significant for us, it is more important to our customers in that they can be confident that the coding software they rely on works in harmony with the dictionaries they use”, said Greg Wagner, ClinPlus Coding Product Manager at DZS.
More information about the Software Certification Program is available at http://www.umc-products.com/certification.
About the Uppsala Monitoring Centre
The Uppsala Monitoring Centre (UMC) provides tools and resources to enhance clinical trials and drug safety operations, ranging from international monitoring of drug safety data to lexicon products and advanced tools for data analysis. Our main products are:
• The WHO Drug Dictionary Enhanced is the world’s most comprehensive dictionary of medicinal product information and de-facto standard for coding concomitant medication in clinical trials and adverse event reporting.
• VigiBase™ – the WHO adverse drug reaction database, which is the world’s largest and most comprehensive resource of international drug safety data.
As a centre of scientific excellence, UMC has extensive experience of database administration and data mining complex sets of clinical data. To advance this work, UMC has developed a range of products and techniques for companies and organizations working with life sciences.
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 60 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite’s unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found in every system!
Posted on Fri, May 06, 2011
DZS/ClinPlus® Introduces ClinPlus CTMS 2.0 with Enhanced Functionality including Framework for Integration with Medidata Rave® Electronic Data Capture System
Clinical Trial Management Solutions Organization Introduces ClinPlus CTMS 2.0 Offering New Software-as-a-Service Model, Integrated Site Visit Report Tools and Automatic Sharing of Trial Data with Medidata Rave EDC/CDM System and others
New York, NY/Bound Brook, NJ – May 5, 2011 – DZS Software Solutions, a specialty provider of ClinPlus® clinical data and trial management services and solutions, today announced the availability of ClinPlus CTMS 2.0. The latest version of ClinPlus CTMS 2.0 offers pharmaceutical, biotech and medical device sponsors and contract research organization (CROs) customers simplified delivery under a new SaaS subscription model in addition to traditional installed and 3rd party hosted delivery options. Enhanced functionality enhances operational visibility beyond the capabilities of earlier versions with the addition of site visit report authoring and review workflow, automated email notification of events and alerts, scheduled report execution with email delivery, enhanced EDC integration and improved data importing capabilities.
A built-in standards-based framework supports automatic transfers of trial data from Medidata Rave®, an industry-leading system for electronic data capture (EDC) and clinical data management (CDM). The system leverages the Medidata Web Services API to automatically transfer critical trial data collected in Rave into ClinPlus CTMS. This data sharing enables sponsors to improve clinical productivity by reducing the amount of duplicate data entry and maintenance, increasing the awareness of data changes through automated notifications and the acceleration of internal processes such as investigator reimbursement approvals. The system also supports data import and export with other systems.
“The rapid sharing of trial data between Medidata Rave and the ClinPlus CTMS will help our customers reduce their trial management burden and run more efficient trials,” says Glen de Vries, President of Medidata.
With an efficient and error-free method of bringing trial data captured within Medidata Rave into ClinPlus CTMS, DZS and Medidata can now serve their customers with rapid, automated transfers of trial data, such as patient enrollment, patient visit, dropout and discontinuance data. The integration with Medidata Rave allows users to schedule and manage import types, key fields, values, data sets and visits.
The addition of the new Site Visit Report Tool feature in ClinPlus CTMS 2.0 will enable CRAs and Project Managers to author and review trip reports, while managing the workflow from first draft through final approval. This new feature will enable clients to configure report templates based on visit type and country, and to integrate CTMS data directly into the trip report. Unlike many other trip report authoring tools, the data entered by the CRA while creating the report is deeply integrated with the main features of the CTMS to reduce data redundancy. Updates to system data elements commonly found in the trip report sections such as regulatory documents, issues, enrollment, SAEs and deviations are done while creating the report and do not need to be re-entered into other areas of the system.
The availability of ClinPlus CTMS in a SaaS delivery model is another extremely important and timely development for many emerging Life Science organizations struggling with the challenges of improving clinical trial productivity while at the same time reducing expenses.
"The appeal of our new SaaS delivery model is its immediate availability to Life Science organizations of all sizes, and its ability to accommodate a wide range of the requirements needed to quickly and effectively deploy the software and get clinical studies up and running in weeks and not months,” said Bob Borysko, DZS’s VP of Product Development. “By improving global user accessibility and communications, tremendous efficiencies and time savings can be realized, manual operations can be reduced and redundant data and tasks can be completely eliminated.”
"DZS continues to focus on improving clinical trial productivity in all phases of the clinical trial process by using technologies that leverage the value of trial data and improve the quality of that data to support regulatory approval for new compounds and medical devices. Our partnership with Medidata Solutions positions DZS to take advantage of a leading EDC breakthrough solution that is quickly becoming a major force in the drug development arena,” said Doron Steger, CEO, DZS Software Solutions.
To speak to a product expert or a personalized demonstration, please contact salesandmarketing@clinplus.com http://www.clinplus.com/ctms-landing---clinplus-clinical-trial-management-copy
Keith W. Ward
Director of Global Marketing & Sales
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
Fax: (732) 764-6755
http://www.linkedin.com/profile
kward@clinplus.com
www.clinplus.com
Posted on Mon, Apr 25, 2011
Clinical data and trial management services and solutions organization unveils productivity enhancement tools including a SDTM to ADaM conversion tool and extensive nine domain template library.
New York, NY/Bound Brook, NJ – April 25, 2011 – DZS Software Solutions, a specialty provider of clinical data and trial management software services and solutions, today announced they will unveil the latest enhancements to their ClinPlus Report Software at the annual SAS User Group meeting in May.
Effectively meeting the clinical data study standards set out by the Clinical Data Interchange Standards Consortium (CDISC) specifically with regards to the Study Data Tabulation Module (SDTM) and the Analysis Data Model (ADaM) has been a significant challenge for many pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers seeking to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies. Converting SDTM data to ADaM data and then to submission ready tables while accurately documenting the process can present an even larger challenge.
Providing complete documentation on the creation of study tables and listings that includes the underlying ADaM data sets; a process by which each variable in the ADaM data set is traced back to its original source and cross referenced to the statistical analysis plan is the first hurdle. CDISC specifications indicate that any variables copied or derived from an SDTM domain and converted into an ADaM data set must retain the integrity of the original data in the SDTM domain. A second hurdle is to produce and present in-text tables and data listings in a highly-readable manner with consistent formatting from table to table and study to study.
In response to these customer challenges, DZS Software developed their ClinPlus® ADaM Data Conversion and Reporting Toolkit, an elegant solution for both metadata-driven conversion of SDTM data to ADaM data and the production of metadata-driven flexible safety tables and listings from the ADaM data. The metadata, defined in Microsoft Excel® spreadsheets becomes the ADaM documentation, thereby eliminating any chance that documentation does not correspond to the actual process.
The second step of producing submission ready safety tables and listings uses ClinPlus’s ADaM Report Generator with the newly converted ADaM data as input. Root templates are provided in nine domains including Demographics, Subject Status, Adverse Events, Concomitant Medication, Medical History, ECG, Physical Exams, Vital Signs and Lab data from which many variations of the default report layout may be generated by altering the parameter values in the report metadata. For instance, an Adverse Events table may display PLACEBO as the first column or last column or the same Adverse Event table can display AEs across Treatment Group or across Severity by manipulating the metadata parameters.
"DZS continues to focus on improving clinical trial productivity in all phases of the clinical trial process, by using technologies that leverage the value of trial data and improve the quality of that data to support regulatory approval for new compounds and medical devices. These powerful software tools position our clients to take advantage of breakthrough technology, gain competitive advantage and collapse their drug development lifecycle.” said Doron Steger, CEO, DZS Software Solutions. To speak to a product expert or arrange a personalized demonstration, please contact salesandmarketing@clinplus.com or follow this link to DOWNLOAD A FREE WHITEPAPER ON ADaM CONVERSION, or request specific information or pricing please go to: http://preview.tinyurl.com/3fuyehq
Posted on Wed, Apr 06, 2011
Clinical Data and Trial Management Services and Solutions Organization Leverages Medidata Rave Web Services API to Enable Data Sharing Between ClinPlus CTMS and Medidata Rave EDC/CDM
New York, NY/Bound Brook, NJ – April 6, 2011 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, and DZS Software Solutions, a specialty provider of clinical data and trial management software services and solutions, today announced the addition of DZS to Medidata’s Technology Partner Program. The partnership recognizes that DZS has enhanced its ClinPlus® clinical trial management system (CTMS) to automatically share trial data with the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform using its Web Services API, eliminating redundant data entry.
DZS works with a range of biotechnology and pharmaceutical organizations worldwide who are trying to improve clinical data and trial management using best-of-breed clinical technologies. In response, DZS has introduced a new version of their ClinPlus CTMS with new functionality that helps overcome a common, complex challenge of sharing trial data between EDC systems and trial management systems. With an efficient and error-free method of bringing trial data captured within Medidata Rave into ClinPlus CTMS, DZS is now better able to serve customers with rapid, automated transfers of trial data, such as patient enrollment, patient visit, dropout and discontinuance data.
Clinical trial sponsors can now utilize both solutions together to further improve trial efficiencies, including faster availability of comprehensive trial data to help reduce redundant or incorrect investigator, patient enrollment and site visit data and support better decision making. With earlier access to patient milestone data, sponsors have the ability to make more timely payments to investigators, which contributes to site satisfaction and retention.
"DZS continues to focus on improving clinical trial productivity in all phases of the clinical trial process by using technologies that leverage the value of trial data and improve the quality of that data to support regulatory approval for new compounds and medical devices. Our partnership with Medidata Solutions positions DZS to take advantage of a leading EDC breakthrough solution that is quickly becoming a major force in the drug development arena,” said Doron Steger, CEO, DZS Software Solutions.
Since its introduction in June of 2009, Medidata's Technology Partner Program has grown to include 12 independent technology vendors that offer specialized solutions supporting data sharing with Medidata products in order to streamline and enhance the end-to-end e-Clinical process.
"We welcome DZS as a Medidata Technology Partner and are excited that our customers have the choice of leveraging DZS’ easily configurable solution to streamline their trial management activities,” said Glen de Vries, president, Medidata Solutions. “DZS designed their solution for customers around the globe who are increasingly looking to efficiently use an advanced CTMS solution alongside Medidata Rave."
To speak to a product expert or arrange a personalized demonstration, please contact salesandmarketing@clinplus.com or follow this link to request specific information or pricing: http://tinyurl.com/4hwgtmk
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite’s unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found in every system!
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Medidata’s advanced solutions address key functions throughout the clinical development process including protocol development (Medidata Designer®), trial planning and management (Medidata Grants Manager®, Medidata CRO Contractor®), user and learning management (iMedidata™), randomization and trial supply management (Medidata Balance™), monitoring (Medidata Rave Monitor, Medidata Rave Targeted SDV), Serious Adverse Events capture (Medidata Rave Safety Gateway) and clinical data capture, management and reporting (Medidata Rave®). Our diverse customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.
Contact:
Lois Paul & Partners
Susan McCarron, 781-782-5767
Susan_McCarron@lpp.com
Source: Medidata Solutions Worldwide
Keith W. Ward
Director of Global Marketing
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
http://www.linkedin.com/profile
kward@clinplus.com
Posted on Thu, Jun 10, 2010
DZS Software Solutions Inc. will unveil new functionality for their suite of clinical trial software products -Data Management, Coding, Report and Clinical Trial Management. Stop By Booth# 927
Bound Brook, NJ - June10, 2010 - DZS Software Solutions, Inc. plans on demonstrating several new enhancements for their clinical solutions at the upcoming DIA Annual Conference in Washington DC, June 13th-16th. (DZS is at Booth #927).
Since 1996, DZS Software Solutions Inc., innovators of the ClinPlus brand of products has been committed to providing the most technologically advanced clinical software products to manage the data of clinical trials, to life science professionals, helping them streamline the clinical trial process and accelerate the process of bringing life-enhancing medicines, biologics and devices to market.
Most recently, DZS responded to industry challenges to increase clinical trial productivity and reduce operating expense by launching a web-based clinical trial management system (CTMS) at last year's DIA Annual in San Diego. Since that time, the system has gained increasing acceptance because of its ability to improve site productivity, eliminate redundant systems and existing manual tasks and help enforce adherence to trial procedures and regulatory compliance. The system also helps provide a real-time trial financial and recruitment picture with immediate access to data about patient recruitment, site payments and supply inventory.
Several newly developed modules will be demonstrated at DIA, including online site visit trip report design and workflow tools (including electronic signatures), automated event notifications and subscriptions to scheduled reports. An upcoming release planned for later this year will include these features, as well as other new capabilities such as SAE worksheet tracking, additional global reporting options, and enhanced subject visit schedules to handle multiple cohorts or cycles.
DZS/ClinPlus has also partnered with APT, an information technology firm located in Allentown, PA, to host ClinPlus(CTMS) and provide Software-as-a-Service subscription model pricing and accessibility for our global customers. The partnership with APT provides value-added technology services for all of the ClinPlus product line to meet the stringent needs of the pharmaceutical industry for 21CFR Part 11 compliance.
In response to the recent clinical data study standards set out by the Clinical Data Interchange Standards Consortium (CDISC), specifically with regards to the Study Data Tabulation Module (SDTM) and the Analysis Data Model (ADaM), DZS enhanced their SAS-based ClinPlus Report software so that adhering to and properly managing these data standards among workgroups, between departments and across the enterprise could be achieved much more efficiently, resulting in dramatic time and cost savings, increased productivity and earlier visibility to reliable clinical data. ClinPlus Report also touts an extensive template library (50+) for generation of CDISC/ ADaM compliant safety tables and listings for ten data domains with supporting documentation in a validated, standardized way.
According to Bob Borysko, VP of Programming and Development at DZS Software Solutions, "These developments underscore our commitment to helping the life science industry meet the challenges of both regulatory and standards-setting bodies as efficiently and effectively as possible." Added Mr. Borysko "Our goal is to offer robust solutions to help our clients leverage these standards and expedite their clinical trials."
To speak to a product expert or arrange a personalized demonstration, please contact sales&marketing@clinplus.com or follow this link to request specific information or pricing: http://www.clinplus.com/products/clinical-trial-management-software?utm_campaign=CTMS-1.1-Promo&utm_source=Fast%20Pitch%2C%20LinkedIn%20Groups
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found every system!
Contact:
Keith W. Ward
Director of Global Marketing
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
Fax: (732) 764-6755
http://www.linkedin.com/profile
kward@clinplus.com
http://www.clinplus.com/
Posted on Tue, Apr 20, 2010
Strategic Alliance between DZS/and APT will facilitate Software-as-a-Service (SaaS) delivery of their recently launched ClinPlus Clinical Trial Management Systems (CTMS) and future Electronic Data Capture (EDC) and Medical Coding applications in a fully validated 21 CFR Part 11 compliant manner.
Bound Brook, NJ - April 19, 2010 - DZS Software Solutions, Inc. and APT Information Technology Consultants of Allentown, PA have formed a strategic alliance for APT to provide clinical information systems management and hosting services via their WebtrialZ offering to enable software delivery as a service (SaaS) for DZS's recently released, web-based clinical trial management software as well as their future EDC and Coding solutions. Both companies plan on demonstrating their solutions at the upcoming ACRP Global Conference in Tampa, FL, April 23rd - 27th. (DZS Booth #529 and APT Booth #229)
SaaS-enabled technologies have gained increased popularity of late because they can be implemented without IT department support, don't require significant up-front capital investment, and eliminate the need for installed servers and the associated maintenance costs. All that's required is an internet connection and browser. Until recently, skeptics have been reluctant to adopt SaaS technology in part because of security concerns. However, using APT's WebtrialZ Services, software applications can be deployed rapidly with the assurance that the data is safe, secure and managed to a level that will meet the 21 CFR Part 11 standards and the most rigorous Pharmaceutical Sponsor audit. APT has extensive experience managing and documenting clinical information systems with services that include the creation and management of IQ/OQ documents for the servers, software and associated equipment, and an established change-management process used to facilitate and document any system changes.
The availability of ClinPlus CTMS in a SaaS delivery model is also an extremely important and timely development for many emerging Life Science organizations struggling with the challenges of improving clinical trial productivity while at the same time reducing expenses. "The appeal of this delivery model is its immediate availability to Life Science companies of all sizes, and its ability to accommodate a wide range of the requirements needed to quickly and effectively deploy the software and get clinical studies up and running in weeks and not months," said Bob Borysko, DZS's VP of Product Development. "By improving global user accessibility and communications, tremendous efficiencies and time-savings can be realized, manual operations can be reduced and redundant data and tasks can be completely eliminated."
To speak to a product expert please contact sales&marketing@clinplus.com or follow this link to request specific information or pricing: http://www.clinplus.com/ctms-landing-clinplus-clinical-trial-management-system-ctms/?utm_campaign=CTMS-ACRP&utm_source=PR-Fastpitch%2C%20Group%20posts
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found every system!
Contact:
Keith W. Ward
Director of Global Marketing
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
Fax: (732) 764-6755
http://www.linkedin.com/profile
kward@clinplus.com
http://www.clinplus.com/
About APT
Founded in 1995 in Allentown, PA, APT Information Technology Consultants is a privately held company which focuses on specialized hosting and critical systems management services. APT serves clients throughout North America, Europe, and the world. Our clients include biotech and pharmaceutical companies, as well as a host of new and emerging businesses.
Our staff of experts has substantial technical experience in the pharmaceutical industry. APT's WebtrialZSM Hosting Service allows customers to focus on their day-to-day business and eliminates the hassle of managing an Information Technology infrastructure. APT provides a seamless extension of a client's IT organization controlled by an extensive set of comprehensive SOPs covering every aspect of system implementation and ongoing management.
Our U.S.-based technical support specialists offer a variety of flexible support options. As a recognized industry leader, APT develops and maintains custom infrastructure support plans while using best practice methodology. APT uses state-of-the-art technologies in hardware, software, and connectivity.
Contact:
Jason Gaston, Technical Sales Consultant
Tammy Long Ferry, Business Development Manager
APT Information Technology Consultants
7540 Windsor Drive, Suite 204
Allentown, PA 18195
Office: (610) 366-1100
Fax: (610) 366-7375
webtrialz@aptconsulting.com
http://www.webtrialz.com/
Posted on Wed, Mar 31, 2010
ClinPlus's CTMS system now available in a software-as-a-service (SaaS) delivery model, offering CRO's, Pharma, Biotech and Medical Device organizations cost-effective subscription model pricing, rapid system deployment, scalability, and site set-up flexibility.
Bound Brook, NJ - March 31, 2010 - DZS Software Solutions, Inc. plans on demonstrating enhanced functionality for its recently released (June 2009) CTMS software solution, part of the ClinPlus Solution Suite at the upcoming ACRP Global Conference in Tampa, FL, April 23rd - 27th. (Booth # 529)
In today's competitive drug development environment, two glaring statistics point to a major obstacle in shortening time-to-market and lowering the cost of clinical trials. First, almost half of the cost of bringing a new drug or device to market, or close to $400 million, is accrued during the clinical trial phase. Second, recent studies also indicate that 75 percent of all trials conducted in the United States are behind schedule by one to six months.
Most of these clinical trials involve a large amount of data, both paper-based and electronic, from thousands of patients, hundreds of sites and a multitude of trial administrators - data that must be collected, transmitted, shared, analyzed, and archived. The good news is that with products like ClinPlus CTMS, companies can reap significant cost and time savings with better visibility and efficient management of their clinical trial information.
The availability of ClinPlus CTMS in a SaaS delivery model is also an extremely important and timely development for many emerging Life Science organizations struggling with the challenges of improving clinical trial productivity while at the same time reducing expenses. "The appeal of this delivery model is its immediate availability to Life Science companies of all sizes, and its ability to accommodate a wide range of the requirements needed to quickly and effectively deploy the software and get clinical studies up and running in weeks and not months," said Bob Borysko, DZS's VP of Product Development. "By improving global user accessibility and communications, tremendous efficiencies and time-savings can be realized, manual operations can be reduced and redundant data and tasks can be completely eliminated."
Because of the continuum of disparate functions and business units that typically exist across pharmaceutical companies, CROs and clinical trial sites, SaaS-enabled technologies have gained increased popularity of late because they can be implemented without IT department support, don't require significant up-front capital investment, and eliminate the need for installed servers and the associated maintenance costs. All that's required is an internet connection and browser.
According to Gartner Research, SaaS Delivery within the Enterprise Application Software markets will show consistent growth through 2013, with worldwide SaaS revenue totaling an estimated $14.4 billion based on total software revenue. In 2008 revenue was $6.4 billion.
Until recently, skeptics have been reluctant to adopt SaaS technology in part because of security concerns. However, using virtualization systems, DZS's SaaS model provides Life Science organizations a distinct and self-contained environment to maintain data protection. Data is also preserved through daily incremental backup and weekly full backup. Other benefits include the ability to scale up or down as needed; round-the-clock accessibility, and complete control over study timelines.
To speak to a product expert or a personalized demonstration, please contact sales&marketing@clinplus.com or follow this link to request specific information or pricing: http://www.clinplus.com/ctms-landing-clinplus-clinical-trial-management-system-ctms/?utm_campaign=CTMS-ACRP&utm_source=PR-Fastpitch%2C%20Group%20posts
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found every system!
Contact:
Keith W. Ward
Director of Global Marketing
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
Fax: (732) 764-6755
http://www.linkedin.com/profile
kward@clinplus.com
www.clinplus.com
Posted on Tue, Feb 23, 2010
Bound Brook, NJ - February 23, 2010 - The United States Military HIV Research Research Program (MHRP) centered at the Division of Retrovirology, Walter Reed Army Institute of Research (WRAIR), Rockville MD has selected and deployed DZS Software Solutions SAS-based ClinPlus Data Management solution to support their worldwide clinical research program.
MHRP remains at the forefront of the battle against HIV to protect U.S. troops from infection and to reduce the global impact of the disease. While its primary focus is developing a globally effective HIV-1 vaccine, the program provides prevention, care and treatment through the President's Emergency Plan for AIDS Relief (PEPFAR).
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 60 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found every system!
Contact DZS Today!
